PTAB Holds that a Pre-Filing Application for a Different Patent Is Not Prior Art Under Pre-AIA 35 U.S.C. § 102(a)

Aug 24, 2017

Reading Time : 1 min

In its IPR petition, Broad-Ocean argued that the ’476 patent is invalid as either anticipated by—or obvious over—another patent, which Broad-Ocean labeled the “Dumser” reference. Specifically, Broad-Ocean asserted that, although the issued Dumser patent was not published until June 2002, the Dumser application was published on July 30, 1997, which was 13 days before the ’476 patent was filed on August 12, 1997. Broad-Ocean argued that Dumser therefore constitutes prior art under pre-AIA 35 U.S.C. § 102(a).

In an opinion authored by Administrative Patent Judge Mitchell G. Weatherly, the PTAB rejected Broad-Ocean’s argument, holding that Broad-Ocean was “not reasonably likely to prevail with respect to at least one of the challenged claims.” The PTAB explained that, in the IPR petition, Broad-Ocean relied on disclosures contained in the issued Dumser patent, rather than disclosures from the Dumser application. The PTAB further found that Broad-Ocean had “present[ed] no evidence that [the issued] Dumser [patent] is identical to the corresponding patent application that was laid open on July 30, 1997.” The PTAB thus concluded that Broad-Ocean “failed to establish that Dumser is prior art” and, in turn, that institution of an IPR therefore was not authorized under 35 U.S.C. § 314(a).

In Broad-Ocean Technologies, Inc. v. Regal Beloit America, Inc., No. IPR2017-00802 (PTAB Aug. 22, 2017)

Share This Insight

Previous Entries

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.